Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney

Nature Medicine volume 2, pages 418–423 (1996)Cite this article

Abstract

There are currently no effective therapies for progressive fibrotic diseases. Recent evidence has implicated overproduction of transforming growth factor–β1 (TGF–β1) as a major cause of tissue fibrosis. Furthermore, this evidence implies that inhibitors of TGF–β1 may be clinically useful as antifibrotic agents. The proteoglycan decorin is a known inhibitor of TGF–β1. In a rat model of glomerulonephritis we have shown that fibrosis is mediated by TGF–β1. We report here that transfer of decorin cDNA into rat skeletal muscle increases the amount of decorin messenger RNA and protein present in skeletal muscle and decorin protein present in kidney, where it has a marked therapeutic effect on fibrosis induced by glomerulonephritis. Transfected glomerulonephritic rats showed a significant reduction in levels of glomerular TGF–β1 mRNA and TGF–β1 protein, extracellular matrix accumulation and proteinuria. These results demonstrate the potential of gene therapy as a novel treatment for fibrotic diseases caused by TGF–β1.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Border, W.A. & Noble, N.A. Transforming growth factor-β in tissue fibrosis. N. Engl J. Med. 331, 1286–1292 (1994).

    Article  CAS  Google Scholar 

  2. Sporn, M.B. & Roberts, A.B. Transforming growth factor β: Recent progress and new challenges. J. Cell Biol. 119, 1017–1921 (1992).

    Article  CAS  Google Scholar 

  3. Border, W.A. & Noble, N.A. Fibrosis linked to TGF-β in yet another disease. J. Clin. Invest. 6, 665 (1995).

  4. Yamaguchi, Y., Mann, D.M. & Ruoslahti, E. Negative regulation of transforming growth factor-β by the proteoglycan decorin. Nature 346, 281–284 (1990).

    Article  CAS  Google Scholar 

  5. Border, W.A. et al. Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease. Nature 360, 361–364 (1992).

    Article  CAS  Google Scholar 

  6. Blau, H.M. & Springer, M.L. Gene therapy — a novel form of drug delivery. N. Engl. J. Med. 333, 1294–1297 (1995).

    Article  Google Scholar 

  7. Blau, H.M. & Springer, M.L. Muscle-mediated gene therapy. N. Engl. J. Med. 333, 1294–1556 (1995).

    Article  Google Scholar 

  8. Marshall, E. Gene therapy's growing pains. Science 269, 1050–1055 (1995).

    Article  CAS  Google Scholar 

  9. Touchette, N. Gene therapy: Not ready for prime time. Nature Med. 2, 7–8 (1996).

    Article  CAS  Google Scholar 

  10. Yamamoto, T. et al. Expression of transforming growth factor-β isoforms in human glomerular diseases. Kidney Int. 49, 461–469 (1996).

    Article  CAS  Google Scholar 

  11. Wolff, J.A. et al. Direct gene transfer into mouse muscle in vivo. Science 247, 1465–1468 (1990).

    Article  CAS  Google Scholar 

  12. Danko, I. & Wolff, J.A. Direct gene transfer into muscle. Vaccine 12, 1499–1502 (1994).

    Article  CAS  Google Scholar 

  13. Tripathy, S.K., Goldwasser, E., Lu, M.-M., Barr, E. & Leiden, J.M. Stable delivery of physiologic levels of recombinant erythropoietin to the systemic circulation by intramuscular injection of replication-defective adenovirus. Proc. Natl. Acad. Sci. USA 91, 11557–11561 (1994).

    Article  CAS  Google Scholar 

  14. Raz, A.A. et al. Systemic immunological effects of cytokine genes injected into skeletal muscle. Proc. Natl Acad. Sci. USA 90, 4523–4527 (1993).

    Article  CAS  Google Scholar 

  15. Kato, K., Kaneda, Y., Sakurai, M., Nakanishi, M. & Okada, Y. Direct injection of hepatitis B virus DNA into liver induced hepatitis in adult rats. J. Biol. Chem. 266, 22071–22074 (1991).

    CAS  PubMed  Google Scholar 

  16. Kaneda, Y., Iwai, K. & Uchida, T. Introduction and expression of the human insulin gene in adult rat liver. J. Biol. Chem. 264, 12126–12129 (1989).

    CAS  PubMed  Google Scholar 

  17. Kaneda, Y., Iwai, K. & Uchida, T. Increased expression of DNA cointroduced with nuclear protein in adult rat liver. Science 243, 375–378 (1989).

    Article  CAS  Google Scholar 

  18. Noble, N.A., Harper, J.R. & Border, W.A. In vivo interactions of TGF-β and extracellular matrix. Prog. Growth Factor Res. 4, 369–382 (1992).

    Article  CAS  Google Scholar 

  19. Van Den Born, J. et al. Monoclonal antibodies against the protein core and glycosaminoglycan side chain of glomerular basement membrane heparan sulfate proteoglycan: Characterization and immunohistological application in human tissues. J. Histochem. Cytochem. 42, 89–102 (1994).

    Article  CAS  Google Scholar 

  20. Felgner, P.L. Genes in a bottle. Lab. Invest. 68, 1–3 (1993).

    CAS  PubMed  Google Scholar 

  21. Border, W.A., Okuda, S., Languino, L.R., Sporn, M.B. & Ruoslahti, E. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1. Nature 336, 371–374 (1990).

    Article  Google Scholar 

  22. Kähäri, V.-M., Larjava, H. & Uitto, J. Differential regulation of extracellular matrix proteoglycan (PG) gene expression. J. Biol. Chem. 266, 10608–10615 (1991).

    PubMed  Google Scholar 

  23. Ruoslahti, E. & Yamaguchi, Y. Proteoglycans as modulators of growth factor activities. Cell 64, 867–869 (1991).

    Article  CAS  Google Scholar 

  24. Border, W.A. & Noble, N.A., TGF-β for treatment of disease. Nature Med. 1, 1000–1001 (1995).

    Article  CAS  Google Scholar 

  25. Dreher, K.L., Asundi, V., Matzura, D. & Cowan, K. Vascular smooth muscle biglycan represents a highly conserved proteoglycan within the arterial wall. Eur. J. Cell Biol. 53, 296–304 (1990).

    CAS  PubMed  Google Scholar 

  26. Asundi, V. & Dreher, K.L. Molecular characterization of vascular smooth muscle decorin: Deduced core protein structure and regulation of gene expression. Eur. J. Cell Biol. 59, 314–321 (1992).

    CAS  PubMed  Google Scholar 

  27. Niwa, H., Yammamura, K. & Miyazaki, J. Efficient selection for high expression transfectants with a novel eukaryotic vector. Gene 108, 193–199 (1991).

    Article  CAS  Google Scholar 

  28. Isaka, Y. et al. Glomerulosclerosis induced by in vivo transfection of transforming growth factor-β or platelet derived growth factor into the rat kidney. J. Clin. Invest. 92, 2597–2601 (1993).

    Article  CAS  Google Scholar 

  29. Takeshita, S. et al. Increased gene expression after liposome-mediated arterial gene transfer associated with intimal smooth muscle cell proliferation. J. Clin. Invest. 93, 652–661 (1994).

    Article  CAS  Google Scholar 

  30. Okuda, S., Languino, L.R., Ruoslahti, E. & Border, W.A. Elevated expression of transforming growth factor-β and proteoglycan production in experimental glomerulonephritis: Possible role in expansion of the mesangial extracellular matrix. J. Clin. Invest. 86, 453–462 (1990).

    Article  CAS  Google Scholar 

  31. Yamamoto, T., Noble, N.A., Miller, D.E. & Border, W.A. Sustained expression of TGF-β1 underlies development of progressive kidney fibrosis. Kidney Int. 45, 916–927 (1994).

    Article  CAS  Google Scholar 

  32. Derynck, R., Jarret, J.A., Chen, E.Y. & Goeddel, D.V. The murine transforming growth factor-β precursor. J. Biol. Chem. 261, 4377–4379 (1986).

    CAS  PubMed  Google Scholar 

  33. Fort, P. et al. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-denydrogenase multigenic family. Nucleic Acids Res. 13, 1431–1443 (1985).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Nephrology, University of Utah School of Medicine, Salt Lake City, Utah, 84132, USA

    Yoshitaka Isaka, Douglas K. Brees, Kazuko Ikegaya, Nancy A. Noble & Wayne A. Border

  2. Institute for Molecular and Cellular Biology, Osaka University, Suita Osaka, 565, Japan

    Yasufumi Kaneda

  3. First Department of Medicine, Osaka University Medical School, Suita Osaka, 565, Japan

    Enyu Imai

Authors
  1. Yoshitaka Isaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Douglas K. Brees
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kazuko Ikegaya
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yasufumi Kaneda
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Enyu Imai
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Nancy A. Noble
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Wayne A. Border
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Isaka, Y., Brees, D., Ikegaya, K. et al. Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nat Med 2, 418–423 (1996). https://doi.org/10.1038/nm0496-418

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0496-418

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing